| Biodistribution of 89Zr‐trastuzumab and PET Imaging of HER2‐Positive Lesions in Patients With Metastatic Breast Cancer EC Dijkers, TH Oude Munnink, JG Kosterink, AH Brouwers, PL Jager, ... Clinical Pharmacology & Therapeutics 87 (5), 586-592, 2010 | 917 | 2010 |
| Clinical relevance of the pharmacokinetic interactions of azole antifungal drugs with other coadministered agents RJM Brüggemann, JWC Alffenaar, NMA Blijlevens, EM Billaud, ... Clinical Infectious Diseases 48 (10), 1441-1458, 2009 | 516 | 2009 |
| Indium-111–labeled trastuzumab scintigraphy in patients with human epidermal growth factor receptor 2–positive metastatic breast cancer PJ Perik, MN Lub-De Hooge, JA Gietema, WTA van der Graaf, ... Journal of clinical oncology 24 (15), 2276-2282, 2006 | 449 | 2006 |
| Development and characterization of clinical-grade 89Zr-trastuzumab for HER2/neu immunoPET imaging ECF Dijkers, JGW Kosterink, AP Rademaker, LR Perk, ... Journal of nuclear medicine 50 (6), 974-981, 2009 | 418 | 2009 |
| Preclinical characterisation of 111In‐DTPA‐trastuzumab MN Lub‐de Hooge, JGW Kosterink, PJ Perik, H Nijnuis, L Tran, J Bart, ... British journal of pharmacology 143 (1), 99-106, 2004 | 293 | 2004 |
| Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies AGTT Van Scheltinga, GM van Dam, WB Nagengast, V Ntziachristos, ... Journal of Nuclear Medicine 52 (11), 1778-1785, 2011 | 260 | 2011 |
| The influence that electronic prescribing has on medication errors and preventable adverse drug events: an interrupted time-series study JE Van Doormaal, PMLA van den Bemt, RJ Zaal, ACG Egberts, ... Journal of the American Medical Informatics Association 16 (6), 816-825, 2009 | 172 | 2009 |
| Applications of stable isotopes in clinical pharmacology RCA Schellekens, F Stellaard, HJ Woerdenbag, HW Frijlink, ... British journal of clinical pharmacology 72 (6), 879-897, 2011 | 168 | 2011 |
| Gastrointestinal pH and transit time profiling in healthy volunteers using the IntelliCap system confirms ileo-colonic release of ColoPulse tablets JM Maurer, RCA Schellekens, HM Van Rieke, C Wanke, V Iordanov, ... PloS one 10 (7), e0129076, 2015 | 156 | 2015 |
| Voriconazole metabolism is influenced by severe inflammation: a prospective study A Veringa, M Ter Avest, LFR Span, ER van den Heuvel, DJ Touw, ... Journal of Antimicrobial Chemotherapy 72 (1), 261-267, 2016 | 150 | 2016 |
| Method for therapeutic drug monitoring of azole antifungal drugs in human serum using LC/MS/MS JWC Alffenaar, AMA Wessels, K Van Hateren, B Greijdanus, ... Journal of Chromatography B 878 (1), 39-44, 2010 | 125 | 2010 |
| Evaluation of moxifloxacin for the treatment of tuberculosis: 3 years of experience AD Pranger, R Van Altena, RE Aarnoutse, D Van Soolingen, DRA Uges, ... European Respiratory Journal 38 (4), 888-894, 2011 | 120 | 2011 |
| Pulsatile drug delivery to ileo-colonic segments by structured incorporation of disintegrants in pH-responsive polymer coatings RCA Schellekens, F Stellaard, D Mitrovic, FE Stuurman, JGW Kosterink, ... Journal of controlled release 132 (2), 91-98, 2008 | 119 | 2008 |
| Inflammation is associated with voriconazole trough concentrations MJP van Wanrooy, LFR Span, MGG Rodgers, ER van den Heuvel, ... Antimicrobial agents and chemotherapy 58 (12), 7098-7101, 2014 | 113 | 2014 |
| The role of fluoroquinolones in the treatment of tuberculosis in 2019 AD Pranger, TS Van Der Werf, JGW Kosterink, JWC Alffenaar Drugs 79 (2), 161-171, 2019 | 110 | 2019 |
| Renal handling of technetium-99m DMSA: evidence for glomerular filtration and peritubular uptake. MJ de Lange, DA Piers, JG Kosterink, WH Van Luijk, S Meijer, ... Journal of nuclear medicine: official publication, Society of Nuclear …, 1989 | 106 | 1989 |
| Clarithromycin increases linezolid exposure in multidrug-resistant tuberculosis patients MS Bolhuis, R van Altena, D van Soolingen, WCM de Lange, DRA Uges, ... European Respiratory Journal 42 (6), 1614-1621, 2013 | 104 | 2013 |
| Medication errors: the impact of prescribing and transcribing errors on preventable harm in hospitalised patients JE Van Doormaal, PMLA van den Bemt, PGM Mol, RJ Zaal, ACG Egberts, ... BMJ Quality & Safety 18 (1), 22-27, 2009 | 102 | 2009 |
| A novel dissolution method relevant to intestinal release behaviour and its application in the evaluation of modified release mesalazine products RCA Schellekens, FE Stuurman, FHJ Van der Weert, JGW Kosterink, ... European journal of pharmaceutical sciences 30 (1), 15-20, 2007 | 101 | 2007 |
| local tumor necrosis factor-α inhibition in inflammatory bowel disease B Gareb, AT Otten, HW Frijlink, G Dijkstra, JGW Kosterink Pharmaceutics 12 (6), 539, 2020 | 99 | 2020 |
